UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035769
Receipt number R000040712
Scientific Title Questionnaire survey for perspectives of patients and doctors on diagnosis and treatment in Parkinson's disease; PD voice study
Date of disclosure of the study information 2019/02/10
Last modified on 2019/05/15 15:00:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Questionnaire survey for perspectives of patients and doctors on diagnosis and treatment in Parkinson's disease; PD voice study

Acronym

PD voice study

Scientific Title

Questionnaire survey for perspectives of patients and doctors on diagnosis and treatment in Parkinson's disease; PD voice study

Scientific Title:Acronym

PD voice study

Region

Japan


Condition

Condition

Parkinson's disease

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

1.Investigation of factors causing delays in diagnosis and treatment initiation

2.Investigation of patients' low satisfaction with treatment

Basic objectives2

Others

Basic objectives -Others

1.The research will confirm the background details of diagnosis and treatment initiation and investigate the actual state and factors causing delays in diagnosis and treatment through questionnaire surveys of patients and doctors.
2.
The research will investigate factors of patients' low satisfaction by analyzing their communications through questionnaire surveys of patients and doctors.

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

<Survey of patients and their families>
1) Disease-related information2) Satisfaction with treatment, satisfaction with consultation
3) Factors inhibiting early diagnosis/early treatment4) Understanding of the disease5) Understanding of the symptoms
6) Awareness of the treatment
<Survey of doctors>
1) Disease-related information2) Satisfaction with treatment, satisfaction with consultation
3) Factors inhibiting early diagnosis and early treatment4) Explanation of the disease5) Understanding of the symptoms6) Awareness of the treatment

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

<Patients and their families>
Subjects must satisfy all of the following criteria.
1)The patient or his/her family had a diagnosis of PD and is visiting hospital.
2)Among 4 major symptoms of PD (postural instability,tremor,rigidity,bradykinesia),the patient (patient or his/her family) has 2 symptoms including bradykinesia.
3)In case of patient's family, he or she can live with the patient and respond on behalf of the patient.
<Doctors>
Subjects must satisfy one of the following criteria according to affiliated department.
1)Neurologists who examined 25 PD patients or more during the last 6 months.
2)Neurosurgeons who examined 5 PD patients or more during the last 6 months.
3)Doctors other than 1) and 2) who examined 10 PD patients or more during the last 6 months.

Key exclusion criteria

no matching the key inclusion criteria

Target sample size

700


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masahiro Nomoto

Organization

The Social Welfare Organization Imperial Gift Foundation Inc,
Saiseikai Imabari Center for Health and Welfare

Division name

Department of Neurology

Zip code


Address

7-6-1 Kitamura, Imabari, Ehime

TEL

0898-47-2500

Email

m-nomoto@imabari.saiseikai.or.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takayuki Ishida

Organization

Takeda Pharmaceutical Company Limited

Division name

Japan Medical Affairs

Zip code


Address

12-10, Nihonbashi 2-chome, Chuo-ku, Tokyo 103-8668

TEL

03-3278-1256

Homepage URL


Email

takayuki.ishida@takeda.com


Sponsor or person

Institute

Takeda Pharmaceutical Company, Limited
Japan Medical Affairs

Institute

Department

Personal name



Funding Source

Organization

Takeda Pharmaceutical Company, Limited
Japan Medical Affairs

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

株式会社マクロミルケアネット (MACROMILL CARENET,INC.)


Other administrative information

Date of disclosure of the study information

2019 Year 02 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 02 Month 01 Day

Date of IRB

2019 Year 02 Month 15 Day

Anticipated trial start date

2019 Year 02 Month 01 Day

Last follow-up date

2019 Year 03 Month 22 Day

Date of closure to data entry

2019 Year 03 Month 26 Day

Date trial data considered complete

2019 Year 03 Month 26 Day

Date analysis concluded

2019 Year 04 Month 22 Day


Other

Other related information

This observational study will be performed in a cross-sectional, non-interventional, single-country format. This research will be conducted as a web-based questionnaire survey. The data obtained in this survey is anonymized, preventing identification of participants.


Management information

Registered date

2019 Year 02 Month 04 Day

Last modified on

2019 Year 05 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040712


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name